Cargando…
SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
Selective serotonin reuptake inhibitors (SSRIs) have anti‐inflammatory properties that may have clinical utility in treating severe pulmonary manifestations of COVID‐19. SSRIs exert anti‐inflammatory effects at three mechanistic levels: (a) inhibition of proinflammatory transcription factor activity...
Autores principales: | Meikle, Claire Kyung Sun, Creeden, Justin Fortune, McCullumsmith, Cheryl, Worth, Randall G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411309/ https://www.ncbi.nlm.nih.gov/pubmed/34254465 http://dx.doi.org/10.1002/npr2.12194 |
Ejemplares similares
-
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
por: Creeden, Justin Fortune, et al.
Publicado: (2021) -
Subcellular partitioning of protein kinase activity revealed by functional kinome profiling
por: Wegman-Points, Lauren, et al.
Publicado: (2022) -
Disclosing the potential impact of placebo controls in antidepressant trials
por: Chen, Stephanie C., et al.
Publicado: (2015) -
12.1 CELL-SUBTYPE SPECIFIC BIOENERGETIC DEFECTS IN SCHIZOPHRENIA
por: Sullivan, Courtney, et al.
Publicado: (2018) -
Using protein turnover to expand the applications of transcriptomics
por: Smail, Marissa A., et al.
Publicado: (2021)